Cullinan Oncology Inc
NASDAQ:CGEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
US |
|
F
|
Factset Research Systems Inc
XMUN:FA1
|
US |
|
Nintendo Co Ltd
OTC:NTDOF
|
JP |
|
C
|
Conocophillips
F:YCP
|
US |
|
B
|
Bajaj Finance Ltd
BSE:500034
|
IN |
|
C
|
Caterpillar Inc
BMV:CAT
|
US |
|
D
|
Danaher Corp
XETRA:DAP
|
US |
|
P
|
Paccar Inc
DUS:PAE
|
US |
|
A
|
Alphabet Inc
F:ABEC
|
US |
|
K
|
Kering SA
MIL:KER
|
FR |
|
Mitsui & Co Ltd
F:MTSA
|
JP |
|
F
|
Ferrari NV
SWB:2FE
|
IT |
|
K
|
Kingspan Group PLC
XMUN:KRX
|
IE |
|
E
|
eBay Inc
SWB:EBA
|
US |
|
C
|
Constellation Brands Inc
XMUN:CB1A
|
US |
|
C
|
China Merchants Port Holdings Co Ltd
SWB:CPM
|
HK |
|
America Movil SAB de CV
F:MV91
|
MX |
|
H
|
HSBC Holdings PLC
BMV:HBCN
|
UK |
|
P
|
PepsiCo Inc
SIX:PEP
|
US |
|
B
|
BlackRock Inc
XBER:BLQA
|
US |
|
3
|
3M Co
SGO:MMM
|
US |
Bankruptcy Probability
Cullinan Oncology Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cullinan Oncology Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
1.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
438.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
225.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
64.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cullinan Oncology Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cullinan Oncology Inc has no debt.
You can find a full breakdown on its Balance Sheet.
